期刊文献+

新型生物活性物质尾加压素Ⅱ在人眼组织的分布 被引量:1

Distribution of new biological activity substance Urotensin-Ⅱ in tissues of human eye
下载PDF
导出
摘要 目的:探讨新型生物活性物质尾加压素Ⅱ(UrotensinⅡ,U-Ⅱ)在人眼组织的分布。方法:将正常新鲜人眼解剖分离出各部分组织并作匀浆后,采用放射免疫测定法检测U-Ⅱ在人眼各组织的分布。结果:U-Ⅱ在人眼各组织均有分布,范围在0.807~32.958ng/g之间,其中以视神经中的含量最高(32.958±1.741ng/g),其后依次为巩膜、虹膜、角膜、睫状体、脉络膜、视网膜、晶状体,玻璃体和房水中的含量最低。视神经中U-Ⅱ含量是房水中的40.4倍。结论:U-Ⅱ广泛分布于人眼各组织,其生理和病理生理作用有待于进一步探讨。 AIM:To study the distribution of Urotensin-Ⅱ(U-Ⅱ),a new biological activity substance in tissues of human eye.METHODS:The different tissues of normal fresh human eye were separated and homogenized,then the distributions of U-Ⅱ were measured by radio-immuno-assay.RESULTS:There were distributions of U-Ⅱ in any tissues of human eye,ranging 0.807-32.958ng/g.The U-Ⅱ content in optic nerve was the highest(32.958±1.741ng/g),then sclera,iris,cornea,ciliary body,choroid,retina and lens in turn.The U-Ⅱ content in vitreous body and aqueous humor were the lowest.The U-Ⅱ content in optic nerve was 40.4 times of that in aqueous humor.CONCLUSION:U-Ⅱ is distributed in tissues of human eye widely.Its effects of physiology and pathophysiology need to further study.
出处 《国际眼科杂志》 CAS 2011年第11期1899-1901,共3页 International Eye Science
基金 中国福建省中医药重点资助项目(No.Wzzb0601)~~
关键词 尾加压素Ⅱ 人眼 分布 Urotensin Ⅱ human eye distribution
  • 相关文献

参考文献13

  • 1Pearson D,Shively JE,Clark BR,et al.Urotensin II:a somatostatin-like peptide in the caudal neurosecretory system of fishes.Proc Natl Acad Sci USA 1980;77(8):5021-5024.
  • 2Luo P,Canziania G,Amesty G,et al.A molecular basis for functional peptide mimicry of carbohydrate antigen.J Biol Chem 2000;275(21):16146-16154.
  • 3Ames RS,Sarau HM,Chambers JK,et al.Human urotensin II is a potent vadioconstrictor and agonist for the orphen receptor GPR14.Nature 1999;401(6750):282-286.
  • 4Coulouarn Y,Lihrmann I,Jegou S,et al.Clonging of cDNA encoding the urotensib precursor in frog and human reveals intense expression of urotensin II gene in motonuurons of the spinal cord.Proc Natl Acad Sci USA 1998;95(26):15803-15808.
  • 5Maguire JJ,Kue RE,Davenport AP.Ophen-receptor ligand human urotensin II:receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1.Br J Pharmacol 2000;131(3):441-446.
  • 6Shenouda A,Douglas SA,Ohlstein EH,et al.Localization of urotensin-II immunoreactivity in normal human kidneys and renal carcinoma.J Histochem Cytochem 2002;50(7):885-889.
  • 7Chakravarth U,Douglas AJ,Bailie JR,et al.Immunoreactive endothelin distribution in ocular tissues.Invest Ophthalmol Vis Sci 1994;35(5):2448.
  • 8Gibson A,Conyears S,Bern HA.The influnce of urotensin II on calcium flux in the rat aorta.J Pharm Pharmacol 1988;40(12):893-895.
  • 9何艳华,洪介民,郭衡山,韦建瑞,陈辉,左辉华,李志樑.尾加压素Ⅱ对培养的心脏成纤维细胞增殖和胶原基因表达的影响[J].第一军医大学学报,2004,24(5):505-508. 被引量:8
  • 10Matsushita M,Shichiri M,Fukai N,et al.Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line,LLCPK1.Endocrinology 2003;144(5):1825-1831.

二级参考文献28

  • 1[1]Colon JM, Yano K, Waugh D, et al. Distribution and molecular forms of urotensin Ⅱ and its role in cardiovascular regulation in vertebrates[J]. J Exp Zool, 1996, 275(2-3): 226-38.
  • 2[2]Coulouarn Y, Lihrmann I, Jegou S, et al. Cloning of the cDNA encoding the urotensin Ⅱ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord[J]. Proc Natl Acad Sci USA, 1998, 95(26): 15803-8.
  • 3[3]Ames RS, Saran HM, Chambers JK, et al. Human urotensin- Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14[J]. Nature, 1999, 401 (6750): 282-6.
  • 4[5]Kelsall C J, Balment RJ. Native urotensins influence cortisol secretion and plasma cortisol concentrations in the euryhaline flounder,platichthys flesus[J]. Gen Comp Endocrinol, 1998, 112(2): 210-9.
  • 5[6]Berm HA, Pearson D, Larson BA, et al. Neurohormones from fish tails: the caudal neurosecretory system. L. "Urophysiology"and the caudal necrosecretory system in fishes [J]. Recent Prog Horm Res,1985, 41 (5): 533-52.
  • 6[7]Maclean MR, Alexander D, Stirrat A, et al. Contractile responses to human urotensin-Ⅱ in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat [J]. Br J Pharmacol, 2000, 130(2): 201-4.
  • 7[8]Maguire J J, Kuc RE, Davenport AP. Orphan-receptor ligand human urotensin Ⅱ: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 [J]. Br J Pharmacol,2000, 131(3): 441-6.
  • 8[9]Douglas SA, Ashton DJ, Sauermelch CF. Human urotensin Ⅱ is a potent vasoactive peptide: pharmacological characterization in the rat, mouse, dog and primate[J]. J Cardiovasc Pharmacol, 2000,36(5 Suppl): S163-6.
  • 9[10]Douglas SA, Sulpizio AC, Piercy V, et al. Differential vasoconstrictor activity of human urotensin-Ⅱ in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey [J]. Br J Pharmacol, 2000, 131(7): 1262-74.
  • 10[11]Hillier C, Berry C, Petrie MC, et al. Effects ofurotensin-Ⅱ in human arteries and veins of varying caliber[J]. Circulation, 2001, 103(10):1378-81.

共引文献24

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部